{"pmid":32297458,"title":"How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","text":["How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved.","PM R","Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K","32297458"],"abstract":["The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved."],"journal":"PM R","authors":["Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297458","week":"202016|Apr 13 - Apr 19","doi":"10.1002/pmrj.12380","keywords":["Telemedicine","rehabilitation","telehealth","virtual visit"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651319664640,"score":8.233237,"similar":[{"pmid":32301818,"title":"Departmental Experience and Lessons Learned With Accelerated Introduction of Telemedicine During the COVID-19 Crisis.","text":["Departmental Experience and Lessons Learned With Accelerated Introduction of Telemedicine During the COVID-19 Crisis.","Despite the use of digital technology in healthcare, telemedicine has not been readily adopted. During the COVID-19 pandemic, healthcare systems have begun crisis management planning. To appropriately allocate resources and prevent virus exposure while maintaining effective patient care, our orthopaedic surgery department rapidly introduced a robust telemedicine program during a 5-day period. Implementation requires attention to patient triage, technological resources, credentialing, education of providers and patients, scheduling, and regulatory considerations. This article provides practical instruction based on our experience for physicians who wish to implement telemedicine during the COVID-19 pandemic. Between telemedicine encounters and necessary in-person visits, providers may be able to achieve 50% of their typical clinic volume within 2 weeks. When handling the massive disruption to the routine patient care workflow, it is critical to understand the key factors associated with an accelerated introduction of telemedicine for the safe and effective continuation of orthopaedic care during this pandemic. LEVEL OF EVIDENCE:: V.","J Am Acad Orthop Surg","Loeb, Alexander E","Rao, Sandesh S","Ficke, James R","Morris, Carol D","Riley, Lee H 3rd","Levin, Adam S","32301818"],"abstract":["Despite the use of digital technology in healthcare, telemedicine has not been readily adopted. During the COVID-19 pandemic, healthcare systems have begun crisis management planning. To appropriately allocate resources and prevent virus exposure while maintaining effective patient care, our orthopaedic surgery department rapidly introduced a robust telemedicine program during a 5-day period. Implementation requires attention to patient triage, technological resources, credentialing, education of providers and patients, scheduling, and regulatory considerations. This article provides practical instruction based on our experience for physicians who wish to implement telemedicine during the COVID-19 pandemic. Between telemedicine encounters and necessary in-person visits, providers may be able to achieve 50% of their typical clinic volume within 2 weeks. When handling the massive disruption to the routine patient care workflow, it is critical to understand the key factors associated with an accelerated introduction of telemedicine for the safe and effective continuation of orthopaedic care during this pandemic. LEVEL OF EVIDENCE:: V."],"journal":"J Am Acad Orthop Surg","authors":["Loeb, Alexander E","Rao, Sandesh S","Ficke, James R","Morris, Carol D","Riley, Lee H 3rd","Levin, Adam S"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301818","week":"202016|Apr 13 - Apr 19","doi":"10.5435/JAAOS-D-20-00380","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664357978691600385,"score":238.57687},{"pmid":32302395,"title":"Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results.","text":["Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results.","The COVID-19 national emergency has led to surging care demand and the need for unprecedented telehealth expansion. Rapid telehealth expansion can be especially complex for pediatric patients. From the experience of a large academic medical center, this report describes a pathway for efficiently increasing capacity of remote pediatric enrollment for telehealth while fulfilling privacy, security, and convenience concerns. The design and implementation of the process took two days. Weekly enrollment subsequently increased 10-fold for children (age 0-12 years) and 1.2-fold for adolescents (age 13-17 years). Weekly telehealth visits increased 200-fold for children and 90-fold for adolescents. The obstacles and solutions presented in this report can provide guidance to health systems for similar challenges during the COVID-19 response and future disasters.","J Am Med Inform Assoc","Patel, Pious D","Cobb, Jared","Wright, Deidre","Turer, Rob","Jordan, Tiffany","Humphrey, Amber","Kepner, Adrienne L","Smith, Gaye","Rosenbloom, S Trent","32302395"],"abstract":["The COVID-19 national emergency has led to surging care demand and the need for unprecedented telehealth expansion. Rapid telehealth expansion can be especially complex for pediatric patients. From the experience of a large academic medical center, this report describes a pathway for efficiently increasing capacity of remote pediatric enrollment for telehealth while fulfilling privacy, security, and convenience concerns. The design and implementation of the process took two days. Weekly enrollment subsequently increased 10-fold for children (age 0-12 years) and 1.2-fold for adolescents (age 13-17 years). Weekly telehealth visits increased 200-fold for children and 90-fold for adolescents. The obstacles and solutions presented in this report can provide guidance to health systems for similar challenges during the COVID-19 response and future disasters."],"journal":"J Am Med Inform Assoc","authors":["Patel, Pious D","Cobb, Jared","Wright, Deidre","Turer, Rob","Jordan, Tiffany","Humphrey, Amber","Kepner, Adrienne L","Smith, Gaye","Rosenbloom, S Trent"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302395","week":"202016|Apr 13 - Apr 19","doi":"10.1093/jamia/ocaa065","keywords":["covid-19","consumer health informatics","patient portals","policy","sars-cov-2","telehealth"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664357978707329024,"score":231.7205},{"pmid":32227596,"title":"Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.","text":["Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.","OBJECTIVE: To outline strategies for the treatment of migraine which do not require in-person visits to clinic or the emergency department, and to describe ways that health insurance companies can remove barriers to quality care for migraine. BACKGROUND: COVID-19 is a global pandemic causing widespread infections and death. To control the spread of infection we are called to observe \"social distancing\" and we have been asked to postpone any procedures which are not essential. Since procedural therapies are a mainstay of headache care, the inability to do procedures could negatively affect our patients with migraine. In this manuscript we review alternative therapies, with particular attention to those which may be contra-indicated in the setting of COVID-19 infection. DESIGN/RESULTS: The manuscript reviews the use of telemedicine visits and acute, bridge, and preventive therapies for migraine. We focus on evidence-based treatment where possible, but also describe \"real world\" strategies which may be tried. In each section we call out areas where changes to rules from commercial health insurance companies would facilitate better migraine care. CONCLUSIONS: Our common goal as health care providers is to maximize the health and safety of our patients. Successful management of migraine with avoidance of in-person clinic and emergency department visits further benefits the current urgent societal goal of maintaining social distance to contain the COVID-19 pandemic.","Headache","Szperka, Christina L","Ailani, Jessica","Barmherzig, Rebecca","Klein, Brad C","Minen, Mia T","Halker Singh, Rashmi B","Shapiro, Robert E","32227596"],"abstract":["OBJECTIVE: To outline strategies for the treatment of migraine which do not require in-person visits to clinic or the emergency department, and to describe ways that health insurance companies can remove barriers to quality care for migraine. BACKGROUND: COVID-19 is a global pandemic causing widespread infections and death. To control the spread of infection we are called to observe \"social distancing\" and we have been asked to postpone any procedures which are not essential. Since procedural therapies are a mainstay of headache care, the inability to do procedures could negatively affect our patients with migraine. In this manuscript we review alternative therapies, with particular attention to those which may be contra-indicated in the setting of COVID-19 infection. DESIGN/RESULTS: The manuscript reviews the use of telemedicine visits and acute, bridge, and preventive therapies for migraine. We focus on evidence-based treatment where possible, but also describe \"real world\" strategies which may be tried. In each section we call out areas where changes to rules from commercial health insurance companies would facilitate better migraine care. CONCLUSIONS: Our common goal as health care providers is to maximize the health and safety of our patients. Successful management of migraine with avoidance of in-person clinic and emergency department visits further benefits the current urgent societal goal of maintaining social distance to contain the COVID-19 pandemic."],"journal":"Headache","authors":["Szperka, Christina L","Ailani, Jessica","Barmherzig, Rebecca","Klein, Brad C","Minen, Mia T","Halker Singh, Rashmi B","Shapiro, Robert E"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227596","week":"202014|Mar 30 - Apr 05","doi":"10.1111/head.13810","keywords":["COVID-19","migraine","telemedicine","treatment"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135316668416,"score":215.93234},{"pmid":32298018,"title":"Head and neck virtual medicine in a pandemic era: lessons from COVID-19.","text":["Head and neck virtual medicine in a pandemic era: lessons from COVID-19.","The 2019 novel coronavirus disease (COVID-19) has presented the world and physicians with a unique public health challenge. In light of its high transmissibility and large burden on the healthcare system, many hospitals and practices have opted to cancel elective surgeries in order to mobilize resources, ration personal protective equipment and guard patients from the virus. Head and neck cancer physicians are particularly affected by these changes given their scope of practice, complex patient population, and interventional focus. In this viewpoint, we discuss some of the many challenges faced by head and neck surgeons in this climate. Additionally, we outline the utility of telemedicine as a potential strategy for allowing physicians to maintain an effective continuum of care. This article is protected by copyright. All rights reserved.","Head Neck","Prasad, Aman","Carey, Ryan M","Rajasekaran, Karthik","32298018"],"abstract":["The 2019 novel coronavirus disease (COVID-19) has presented the world and physicians with a unique public health challenge. In light of its high transmissibility and large burden on the healthcare system, many hospitals and practices have opted to cancel elective surgeries in order to mobilize resources, ration personal protective equipment and guard patients from the virus. Head and neck cancer physicians are particularly affected by these changes given their scope of practice, complex patient population, and interventional focus. In this viewpoint, we discuss some of the many challenges faced by head and neck surgeons in this climate. Additionally, we outline the utility of telemedicine as a potential strategy for allowing physicians to maintain an effective continuum of care. This article is protected by copyright. All rights reserved."],"journal":"Head Neck","authors":["Prasad, Aman","Carey, Ryan M","Rajasekaran, Karthik"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298018","week":"202016|Apr 13 - Apr 19","doi":"10.1002/hed.26174","keywords":["COVID-19","Head and neck oncology","Health systems","Patient-physician communication","Telemedicine"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651277721601,"score":213.42064},{"pmid":32298480,"title":"Management of Infantile Hemangiomas during the COVID Pandemic.","text":["Management of Infantile Hemangiomas during the COVID Pandemic.","The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of infantile hemangiomas via telemedicine. FDA/EMA approved monitoring guidelines, clinical practice guidelines and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation are included. The importance of communication with caregivers in the context of telemedicine is discussed and online resources for both hemangioma education and for propranolol therapy provided.","Pediatr Dermatol","Frieden, Ilona J","Puttgen, Katherine B","Drolet, Beth A","Garzon, Maria C","Chamlin, Sarah L","Pope, Elena","Mancini, Anthony J","Lauren, Christine T","Mathes, Erin F","Siegel, Dawn H","Gupta, Deepti","Haggstrom, Anita N","Tollefson, Megha M","Baselga, Eulalia","Morel, Kimberly D","Shah, Sonal D","Holland, Kristen E","Adams, Denise M","Horii, Kimberly A","Newell, Brandon D","Powell, Julie","McCuaig, Catherine C","Nopper, Amy J","Metry, Denise W","Maguiness, Sheilagh","32298480"],"abstract":["The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of infantile hemangiomas via telemedicine. FDA/EMA approved monitoring guidelines, clinical practice guidelines and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation are included. The importance of communication with caregivers in the context of telemedicine is discussed and online resources for both hemangioma education and for propranolol therapy provided."],"journal":"Pediatr Dermatol","authors":["Frieden, Ilona J","Puttgen, Katherine B","Drolet, Beth A","Garzon, Maria C","Chamlin, Sarah L","Pope, Elena","Mancini, Anthony J","Lauren, Christine T","Mathes, Erin F","Siegel, Dawn H","Gupta, Deepti","Haggstrom, Anita N","Tollefson, Megha M","Baselga, Eulalia","Morel, Kimberly D","Shah, Sonal D","Holland, Kristen E","Adams, Denise M","Horii, Kimberly A","Newell, Brandon D","Powell, Julie","McCuaig, Catherine C","Nopper, Amy J","Metry, Denise W","Maguiness, Sheilagh"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298480","week":"202016|Apr 13 - Apr 19","doi":"10.1111/pde.14196","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651314421760,"score":212.55519}]}